Stay updated on Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page.

Latest updates to the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page
- Check2 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2; the Back to Top element was removed as a minor UI change.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated to include a new publication from PubMed regarding the safety of tralokinumab in patients with moderate-to-severe atopic dermatitis, along with a revision update from v3.0.0 to v3.0.1.SummaryDifference3%
- Check17 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of topics related to drug safety and counterfeit drugs. Notably, the revision version has been updated from v2.16.12 to v3.0.0.SummaryDifference5%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.8%
Stay in the know with updates to Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stem Cell Dose Efficacy in Buerger's Disease Clinical Trial page.